DRC launches first Ebola treatment trials in Bunia epicenter

Clinical trials for Ebola vaccines and therapeutics have begun in Bunia, DRC, targeting the current outbreak epicenter. The trials aim to reduce transmission and improve survival rates, though efficacy data is pending. This marks a critical step in outbreak response, but operational challenges in the region may hinder rollout.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works